Phathom Pharmaceuticals, Inc. (PHAT) Tops Q3 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts PHAT Hot Sheet
Join SI Premium – FREE
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) reported Q3 EPS of ($0.76), $0.13 better than the analyst estimate of ($0.89).
For earnings history and earnings-related data on Phathom Pharmaceuticals, Inc. (PHAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- aTyr Pharma (LIFE) Reports Q3 EPS of $0.53; Offers Guidance
- TETRA Technologies (TTI) Tops Q3 EPS by 1c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
